2017 - IPITA


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Pancreas Donation, Procurement & Preservation 2

37.2 - Normothermic regional perfusion (NRP) for DCD simultaneous pancreas and kidney (SPK) transplantation: initial experience

Presenter: G, Defries, Cambridge, United Kingdom
Authors: Gail Defries, Stephanie Smith, Andrew Butler, Christopher Watson

Normothermic regional perfusion (NRP) for DCD simultaneous pancreas and kidney (SPK) transplantation: initial experience

G. Defries1, S. Smith1, A. Butler1,2, C. Watson1,2.

1Transplant, Cambridge University Hospitals Trust, Cambridge, UK, ; 2Department of Surgery, Cambridge University, Cambridge, UK,

Introduction: Normothermic regional perfusion (NRP) in donation after circulatory death (DCD) donors restores an oxygenated circulation to the abdominal organs for 2 hours before in situ cold perfusion. We evaluated the outcomes of DCD pancreases undergoing this treatment with a contemporaneous cohort of DCD and DBD pancreas transplants.
Methods: The records of all recipients of DCD and DBD SPK transplants since the introduction of NRP were reviewed.
Results: Between March 2013 and August 2016,9 patients have undergone an SPK transplant from a donor who underwent NRP at retrieval; these were compared with 22 non-NRP DCD SPK transplants and 55 DBD SPK transplants in the same period, and followed up until 1/2/2017. All patients received the same immuno­suppressive protocol. The table illustrates the difference in outcomes. 

 

NRP SPKs

(n=11)

Standard DCD SPKs

(n=22)

DBD SPK transplants

(n=55)

Donor   age (median, range)

26 (17-48)

30 (14-56)

35 (7-56)

Recipient   age (median, range)

38 (24-52)

45 (32-56)

46 (27-56)

Pre-dialysis

27%

23%

13%

Cold   ischaemic times: pancreas

507min   (361-930)

657min   (286-817)

645min   (362-868)

Cold   ischaemic times: kidney

694min   (550-1175)

793min   (545-1031)

821min   (530-1071)

Pancreas   delayed graft function

0

5%

4%

No   of reoperations

4/9=44%

6/22=27%

11/55=20%

Length   of stay (median/IQR)

16 days (10-29)

25 days   (11-28)

13 days (10-21)

1   year actuarial pancreas graft survival

90.9%

95.2%

93.8%

There were no deaths in either DCD group and no kidneys were lost; there was a single death following DBD SPK transplantation and one kidney lost. In the NRP group the single pancreas loss was due to early graft thrombosis; in the standard DCD group the graft that was lost had undergone a partially successful portal vein thrombectomy early post transplant but eventually failed at 140 days.
Discussion: The NRP DCD SPK group involved the youngest donors and recipients, with more recipients pre-dialysis at the time of transplant. In spite of that these initial data show no benefit of NRP for patients undergoing SPK transplantation.  The results from DCD SPK transplants are similar to DBD SPK transplants.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada